57,48 47,50 hors TVA

H157

Spastic Ataxia in Great Pyrenees is a hereditary neurological disorder caused by an autosomal recessive mutation in the Sacsin molecular chaperone (SACS) gene.

10 working days

Excl €5,95 shipping and administration per order (incl. VAT)

Caractéristiques

Breeds

Gene

Organ

specimen

Écouvillonnage, sanguin EDTA, sanguine hépariné, sperme, tissu

Mode of Inheritance

Chromosome

Year Published

Informations générales

Spastic Ataxia in Great Pyrenees is a hereditary neurological disorder caused by an autosomal recessive mutation in the Sacsin molecular chaperone (SACS) gene. This gene plays a critical role in the health of long nerve fibers in the brain and spinal cord. The mutation leads to the degradation of these long nerve fibers, leading to loss of coordination and movement problems. The disorder is similar to the human spastic ataxia of Charlevoix-Saguenay (ARSACS).

Caractéristiques cliniques

Affected dogs typically begin showing symptoms around 4 months of age, including clumsiness, uncoordinated movements, tremors and difficulty walking—especially on slippery surfaces. They may appear reluctant to climb stairs or jump, often leaning on walls or fences for support and preferring to lie down frequently. As the disease progresses, dogs develop increasing hind limb weakness, balance issues, and general muscle stiffness. Most dogs gradually lose mobility and are euthanized between 4 to 7 years of age due to the progressive nature of the condition.

Additional Information

Références

Pubmed ID: 37758910

Omia ID: 2780

Comment ça marche?

1. Sélectionnez vos produits

Sélectionnez un seul test, un package CombiBreed ou créez votre propre package.

2. Prélevez un échantillon d’ADN

Prélevez le matériel d’ADN comme indiqué avec nos produits et envoyez-le au laboratoire.

3. Résultat

Nous traitons votre commande avec soin et vous communiquons les résultats.